{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:04:19Z","timestamp":1771002259312,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,4,23]],"date-time":"2005-04-23T00:00:00Z","timestamp":1114214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00467-005-1862-4","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T13:43:52Z","timestamp":1114609432000},"page":"977-981","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients"],"prefix":"10.1007","volume":"20","author":[{"given":"Rita D.","family":"Sheth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"L.Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,23]]},"reference":[{"key":"1862_CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"1862_CR2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO (4), Ca x PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131\u20132138","journal-title":"J Am Soc Nephrol"},{"key":"1862_CR3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","volume":"35","author":"Block","year":"2000","unstructured":"Block GA, Port FK (2000) Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35:1226\u20131237","journal-title":"Am J Kidney Dis"},{"key":"1862_CR4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0031-3955(16)40097-0","volume":"42","author":"Salusky","year":"1995","unstructured":"Salusky IB (1995) Bone and mineral metabolism in childhood end-stage renal disease. Pediatr Clin North Am 42:1531\u20131550","journal-title":"Pediatr Clin North Am"},{"key":"1862_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semnephrol.2003.08.019","volume":"24","author":"Martin","year":"2004","unstructured":"Martin KJ, Akhtar I, Gonzalez EA (2004) Parathyroid hormone: new assays, new receptors. Semin Nephrol 24:3\u20139","journal-title":"Semin Nephrol"},{"key":"1862_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1525-139X.2002.00053.x","volume":"15","author":"Brossard","year":"2002","unstructured":"Brossard JH, Yamamoto LN, D\u2019Amour P (2002) Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications. Semin Dial 15:196\u2013201","journal-title":"Semin Dial"},{"key":"1862_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000182629","volume":"31","author":"von","year":"1982","unstructured":"von Lilienfeld-Toal H, Gerlach I, Klehr HU, Issa S, Keck E (1982) Immunoreactive parathyroid hormone in early and advanced renal failure. Nephron 31:116\u2013122","journal-title":"Nephron"},{"key":"1862_CR8","unstructured":"Slatopolsky E, Hruska K, Rutherford WE (1975) Current concepts of parathyroid hormone and vitamin D metabolism: perturbations in chronic renal disease. Kidney Int [Suppl]:90\u201396"},{"key":"1862_CR9","first-page":"309","volume":"99","author":"Slatopolsky","year":"1982","unstructured":"Slatopolsky E, Martin K, Morrissey J, Hruska K (1982) Current concepts of the metabolism and radioimmunoassay of parathyroid hormone. J Lab Clin Med 99:309\u2013316","journal-title":"J Lab Clin Med"},{"key":"1862_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI108077","volume":"56","author":"Hruska","year":"1975","unstructured":"Hruska KA, Kopelman R, Rutherford WE, Klahr S, Slatopolsky E, Greenwalt A, Bascom T, Markham J (1975) Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J Clin Invest 56:39\u201348","journal-title":"J Clin Invest"},{"key":"1862_CR11","first-page":"457","volume":"11","author":"Hruska","year":"1975","unstructured":"Hruska K, Kopelman R, Rutherford WE, Greenwalt A, Klahr S, Slatopolsky E (1975) Parathyroid hormone (PTH) metabolism in chronic renal disease (CRD). Proc Eur Dial Transplant Assoc 11:457\u2013464","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"1862_CR12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","volume":"58","author":"Slatopolsky","year":"2000","unstructured":"Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753\u2013761","journal-title":"Kidney Int"},{"key":"1862_CR13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/ajkd.2002.34519","volume":"40","author":"Coen","year":"2002","unstructured":"Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F, Manni M, Morosetti M, Moscaritolo E, Sardella D (2002) PTH 1-84 and PTH \u201c7-84\u201d in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:38\u2013354","journal-title":"Am J Kidney Dis"},{"key":"1862_CR14","doi-asserted-by":"crossref","unstructured":"Goodman WG (2003) New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure. Kidney Int [Suppl]:S120\u2013124","DOI":"10.1046\/j.1523-1755.64.s87.18.x"},{"key":"1862_CR15","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","volume":"60","author":"Monier-Faugere","year":"2001","unstructured":"Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH (2001) Improved assessment of bone turnover by the PTH-(1-84)\/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460\u20131468","journal-title":"Kidney Int"},{"key":"1862_CR16","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","volume":"63","author":"Salusky","year":"2003","unstructured":"Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Juppner H (2003) Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63:1801\u20131808","journal-title":"Kidney Int"},{"key":"1862_CR17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfg144","volume":"18","author":"Reichel","year":"2003","unstructured":"Reichel H, Esser A, Roth HJ, Schmidt-Gayk H (2003) Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18:759\u2013768","journal-title":"Nephrol Dial Transplant"},{"key":"1862_CR18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00467-003-1267-1","volume":"18","author":"Waller","year":"2003","unstructured":"Waller S, Reynolds A, Ridout D, Cantor T, Gao P, Rees L (2003) Parathyroid hormone and its fragments in children with chronic renal failure. Pediatr Nephrol 18:1242\u20131248","journal-title":"Pediatr Nephrol"},{"key":"1862_CR19","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1523-1755.2003.00262.x","volume":"64","author":"Santamaria","year":"2003","unstructured":"Santamaria R, Almaden Y, Felsenfeld A, Martin-Malo A, Gao P, Cantor T, Aljama P, Rodriguez M (2003) Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays. Kidney Int 64:1867\u20131873","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-1862-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-005-1862-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-1862-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T22:28:40Z","timestamp":1625869720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-005-1862-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,23]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["1862"],"URL":"https:\/\/doi.org\/10.1007\/s00467-005-1862-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,23]]}}}